Cargando…
Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used,...
Autores principales: | Kang, Seung Hyun, Lee, Chang-Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Biotechnology and Bioengineering
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236339/ https://www.ncbi.nlm.nih.gov/pubmed/34220207 http://dx.doi.org/10.1007/s12257-020-0181-8 |
Ejemplares similares
-
Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted Cancer Therapeutics
por: Kim, Eunhee G., et al.
Publicado: (2015) -
Therapeutic modulation of inflammasome pathways
por: Chauhan, Dhruv, et al.
Publicado: (2020) -
Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022) -
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology
por: Chatelut, Etienne, et al.
Publicado: (2021) -
Development of therapeutic antibodies for the treatment of diseases
por: Lu, Ruei-Min, et al.
Publicado: (2020)